Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,454.00
Bid: 1,452.00
Ask: 1,454.00
Change: 21.00 (1.47%)
Spread: 2.00 (0.138%)
Open: 1,425.00
High: 1,458.00
Low: 1,425.00
Prev. Close: 1,433.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Indivior Raises 2020 Revenue Guidance

Fri, 15th Jan 2021 07:49

(Alliance News) - Stock prices in London are seen opening lower on Friday in the wake of the stimulus plan announced by the incoming Biden administration, as focus now shifts to the plan being passed into law.

In early company news, industrial software company Aveva Group expressed confidence in its prospects. British American Tobacco said it would not face any action from the UK Serious Fraud Office, and drugmaker Indivior raised revenue guidance.

IG futures indicate the FTSE 100 index is to open 30.76 points lower at 6,771.20. The blue-chip index closed up 56.44 points, or 0.8%, at 6,801.96 Thursday.

Aveva Group said it saw a positive performance in for the three months ended December 31. The industrial software company said organic constant currency revenue growth in the period was over 26%. This was driven by a significant number of scheduled subscription renewals, including a large three-year contract renewal in the Food sector, it noted.

Aveva said contract renewals helped improve revenue growth to 1.5% in the nine months to December 31 on an organic constant currency basis. On the same basis, recurring revenue grew by 10%, taking it to 68% of overall revenue in the period.

"The board remains confident in the full year outlook for AVEVA. Notwithstanding the disruption seen to the trading environment in 2020, the trend towards the digitalisation of the industrial world is strong and the board remains excited about the significant growth opportunities ahead," the company said.

British American Tobacco said it has been informed by the UK Serious Fraud Office that the UK regulator has discontinued the investigation of suspicions of corruption by the company.

The SFO had opened a formal investigation in 2017 into possible misconduct by the Dunhill cigarette maker in Africa.

BAT said it was is pleased that the SFO has closed its investigation, and that the SFO is taking no further action on the matter.

Indivior raised its 2020 revenue guidance to a range between USD645 million and GBP650 million from a previous guided range of USD595 million to GBP620 million.

In addition, Indivior lifted its 2020 net revenue guidance for Sublocade to USD128 million to GBP130 million from USD120 million to GBP125 million. Sublocade, a treatment for opioid addiction, has seen benefits from modest stocking activity in the US in the fourth quarter, the company said.

As such, Indivior expects to deliver adjusted pretax profit ahead of its previous expectations.

The pound was quoted at USD1.3672 on Friday morning, lower from USD1.3681 at the London equities close Thursday, after data showed the UK economy shrank in November.

On a monthly basis, the UK gross domestic product shrank 2.6% in November after posting 0.6% growth in October, as restrictions were in place to varying degrees across all four nations of the UK during November.

The euro stood at USD1.2140, slightly lower from USD1.2145. Against the yen, the dollar was trading at JPY103.74, flat from JPY103.72.

US President-elect Joe Biden will propose injecting USD1.9 trillion into the economy when he takes office next week, as evidence mounts that the recovery from the sharp downturn caused by Covid-19 is flagging.

Dubbed the American Rescue Plan, the proposal released Thursday includes a host of measures aimed at revitalizing the world's largest economy.

The plans include an extra USD1,400 cash handout for individuals - to top up the USD600 in last month's stimulus - a hike in the minimum wage to USD15 an hour, and billions of dollars to ramp up vaccinations so that 100 million are administered in 100 days.

Top Senate Democrat Chuck Schumer and House Speaker Nancy Pelosi embraced Biden's plan, vowing to put it before lawmakers.

In the US on Thursday, Wall Street ended lower, with the Dow Jones Industrial Average down 0.2%, S&P 500 down 0.4% and Nasdaq Composite down 0.1%.

The Japanese Nikkei 225 index closed down 0.6%. In China, the Shanghai Composite closed flat, while the Hang Seng index in Hong Kong is down 0.1%.

"Seems like this was already priced in, at least as far as magnitude," said Ilya Spivak, analyst at DailyFX. "The main question is how much of it gets compromised away to get it passed. That is probably the next layer of speculative uncertainty that markets are focused on. Hence the muted response."

Meanwhile, the US could see a boost of "exuberant spending" after the pandemic that causes price increases, but that may not lead to a spike in inflation, US Federal Reserve Chair Jerome Powell said on Thursday.

"As the pandemic recedes and we see potentially a strong wave of spending as people return to their normal lives and begin consuming various services, there could be quite exuberant spending and we could see some upward pressure on prices," Powell said during a talk hosted by Princeton University.

The Fed last year unveiled a new inflation targeting policy that will keep interest rates at zero for an extended period, and allow inflation to rise beyond 2.0% for a time in an effort to promote full employment.

Powell did not predict a post-pandemic consumer spending spree would lead to meaningfully higher inflation, but said if that did happen, the central bank is prepared.

Brent oil was trading at USD55.65 a barrel, flat from USD55.69 a barrel at the London equities close Thursday. Gold was priced at USD1,851.74 an ounce, higher than USD1,847.36.

Friday's economic calendar has US retail sales at 1330 GMT followed by US industrial production at 1415 GMT.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
24 Jun 2022 12:40

IN BRIEF: Indivior settles patent infringement case with DRL

Indivior PLC - Richmond, Virginia-based pharmaceutical firm - Enters into a settlement agreement with Indian pharmaceutical company Dr Reddy's Laboratories Ltd and its subsidiaries together with Aquestive Therapeutics Inc. Explains that the settlement is for a patent infringement case regarding DRL's generic buprenorphine and naloxone sublingual film that is equivalent to its Suboxone sublingual film.

Read more
24 Jun 2022 12:11

Indivior settles patent litigation with Dr. Reddy's

(Sharecast News) - Opioid addiction treatment maker Indivior has settled a patent infringement case with generic drug maker Dr. Reddy's Laboratories.

Read more
1 Jun 2022 19:41

TRADING UPDATES: Indivior, Diurnal start trials; Alien Metals tests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
3 May 2022 09:48

Indivior commences USD100 million share buyback programme

(Alliance News) - Indivior PLC on Tuesday said it has commenced a share buyback programme for up to USD100 million, signing a non-discretionary agreement with Stifel Nicolaus Europe Ltd in relation to the programme.

Read more
28 Apr 2022 16:04

UK shareholder meetings calendar - next 7 days

Friday 29 April  
ADVFN PLCGM re director appointments
AstraZeneca PLCAGM
BBGI Global Infrastructure SAAGM
GreenCoat Renewables PLCAGM
Holders Technology PLCAGM
HSBC Holdings PLCAGM
JPMorgan Claverhouse Investment Trust PLCAGM
Kingspan Group PLCAGM
Minoan Group PLCAGM
Nostrum Oil & Gas PLCGM - re notes restructuring
Pearson PLCAGM
Photo-Me International PLCAGM
Rotork PLCAGM
Smurfit Kappa Group PLCAGM
Travis Perkins PLCAGM
Monday 2 May 
no events scheduled 
Tuesday 3 May 
AVI Japan Opportunity Trust PLCAGM
CPPGroup PLCAGM
F&C Investment Trust PLCAGM
IOG PLCAGM
Plus500 LtdAGM
Smithson Investment Trust PLCAGM
Wednesday 4 May 
Barclays PLCAGM
Caledonia Mining Corp PLCAGM
CentralNic Group PLCAGM
GlaxoSmithKline PLCAGM
Just Eat Takeaway.com NVAGM
Ocado Group PLCAGM
RIT Capital Partners PLCAGM
Safestyle UK PLCAGM
Standard Chartered PLCAGM
Ten Entertainment Group PLCAGM
Tribal Group PLCAGM
Tritax Big Box REIT PLCAGM
Unilever PLCAGM
Thursday 5 May 
AIB Group PLCAGM
Alpha FX Group PLCAGM
Apax Global Alpha LtdAGM
Ascential PLC AGM
Avast PLCAGM
BAE Systems PLCAGM
Ceres Power Holdings PLCAGM
Clarkson PLCAGM
Costain Group PLCAGM
Domino's Pizza Group PLCAGM
EJF Investments LtdEGM re rollover offer
Emis Group PLCAGM
GetBusy PLCAGM
Glanbia PLCAGM
Griffin Mining LtdAGM
IMI PLCAGM
Indivior PLCAGM
James Fisher & Sons PLCAGM
Jardine Matheson Holdings LtdAGM
John Wood Group PLCAGM
KRM22 PLCAGM
Made.com Group PLCAGM
Melrose Industries PLCAGM
Mincon Group PLCAGM
MoneySupermarket.com PLCAGM
Morgan Advanced Materials PLCAGM
Morgan Sindall Group PLCAGM
Personal Group Holdings PLCAGM
Quixant PLCAGM
Rathbones Group PLCAGM
Reach PLCAGM
Scotgems PLCAGM
Witan Investment Trust PLCAGM
Sancus Lending Group LtdAGM
React Group PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
28 Apr 2022 11:59

Indivior set to meet full-year guidance; announces buyback

(Alliance News) - Indivior PLC said on Thursday its strong start to 2022 had put it on track to meet its annual guidance as the company also announced a new USD100 million buyback.

Read more
28 Apr 2022 07:53

Indivior maintains guidance after 'strong start' to year

(Sharecast News) - Pharmaceuticals firm Indivior reported first quarter net revenue of $207m (£165.07m) in an update on Thursday, up 15% year-on-year, as it maintained its guidance for the full year.

Read more
4 Apr 2022 09:47

LONDON BROKER RATINGS: Barclays downgrades Aviva and raises Just Group

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
31 Mar 2022 15:26

Indivior starts formal shareholder talks over additional US listing

(Sharecast News) - Opioid addiction treatment maker Indivior said on Thursday that it is beginning formal consultations with shareholders about a potential additional listing of its shares in the US.

Read more
25 Mar 2022 09:46

LONDON BROKER RATINGS: Next and B&M raised; British Land cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
25 Mar 2022 08:20

LONDON BRIEFING: Petropavlovsk warns bank sanctions to hit gold sales

(Alliance News) - Russian gold miner Petropavlovsk on Friday warned it has a USD200 million term loan and a USD86.7 million revolving credit facility with Gazprombank, a bank which now has been sanctioned by the UK, in the wake of Russia's invasion of Ukraine.

Read more
15 Mar 2022 16:49

DIRECTOR DEALINGS: Indivior chief HR officer sells; Volex COO buys

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and not separately reported by Alliance News:

Read more
18 Feb 2022 14:17

IN BRIEF: Indivior strategy chief Simkin sells GBP800,000 in shares

Indivior PLC - North Chesterfield, Virginia-based treatments for opioid addiction - Chief Commercial & Strategy Officer Richard Simkin sells 300,000 shares at GBP2.70, worth GBP810,000, on Thursday. The sale represented just under half of his Indivior shareholding, retaining 340,025 shares. Indivior on Wednesday had reported a swing to profit in 2021 and said it is considering a US share listing.

Read more
16 Feb 2022 17:06

LONDON MARKET CLOSE: Stocks edge lower on doubts over Russia pullback

(Alliance News) - Stocks in London on Wednesday ended on a subdued note amid doubts over the reported pullback of Russian forces from the Ukraine borders.

Read more
16 Feb 2022 12:02

LONDON MARKET MIDDAY: Stocks struggle as NATO doubts Russia withdrawal

(Alliance News) - European equities were mixed midday Wednesday as a tense situation on the Ukraine border and a staggering UK inflation figure saw trepidation creep in, with markets surrendering earlier gains.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.